Xinglan He
Changsha, 410011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
m6A RNA methylation: The latent string-puller in fibrosis.
Journal: Life sciences
Published: February 12, 2024
Silica's silent threat: Contributing to skin fibrosis in systemic sclerosis by targeting the HDAC4/Smad2/3 pathway.
Journal: Environmental pollution (Barking, Essex : 1987)
Published: January 23, 2024
Pyroptosis: the potential eye of the storm in adult-onset Still's disease.
Journal: Inflammopharmacology
Published: April 15, 2023
ATRA ameliorates fibrosis by suppressing the pro-fibrotic molecule Fra2/AP-1 in systemic sclerosis.
Journal: International immunopharmacology
Published: March 05, 2023
Intimate intertwining of the pathogenesis of hypoxia and systemic sclerosis: A transcriptome integration analysis.
Journal: Frontiers in immunology
Published: April 26, 2022
Nonsense Suppression Therapy: An Emerging Treatment for Hereditary Skin Diseases.
Journal: Acta dermato-venereologica
Published: January 27, 2022
Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target.
Journal: Frontiers in immunology
Published: December 22, 2021
Overexpression of OASL upregulates TET1 to induce aberrant activation of CD4+ T cells in systemic sclerosis via IRF1 signaling.
Journal: Arthritis research & therapy
Published: September 17, 2021
Diallyl disulphide inhibits apolipoprotein(a) expression in HepG2 cells through the MEK1-ERK1/2-ELK-1 pathway.
Journal: Lipids in health and disease
Published: August 29, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026